Back to Search Start Over

The clinical case for proton beam therapy

Authors :
Foote Robert L
Stafford Scott L
Petersen Ivy A
Pulido Jose S
Clarke Michelle J
Schild Steven E
Garces Yolanda I
Olivier Kenneth R
Miller Robert C
Haddock Michael G
Yan Elizabeth
Laack Nadia N
Arndt Carola A S
Buskirk Steven J
Miller Vickie L
Brent Christopher R
Kruse Jon J
Ezzell Gary A
Herman Michael G
Gunderson Leonard L
Erlichman Charles
Diasio Robert B
Source :
Radiation Oncology, Vol 7, Iss 1, p 174 (2012)
Publication Year :
2012
Publisher :
BMC, 2012.

Abstract

Abstract Over the past 20 years, several proton beam treatment programs have been implemented throughout the United States. Increasingly, the number of new programs under development is growing. Proton beam therapy has the potential for improving tumor control and survival through dose escalation. It also has potential for reducing harm to normal organs through dose reduction. However, proton beam therapy is more costly than conventional x-ray therapy. This increased cost may be offset by improved function, improved quality of life, and reduced costs related to treating the late effects of therapy. Clinical research opportunities are abundant to determine which patients will gain the most benefit from proton beam therapy. We review the clinical case for proton beam therapy. Summary sentence Proton beam therapy is a technically advanced and promising form of radiation therapy.

Details

Language :
English
ISSN :
1748717X
Volume :
7
Issue :
1
Database :
Directory of Open Access Journals
Journal :
Radiation Oncology
Publication Type :
Academic Journal
Accession number :
edsdoj.03bda32e844641a88347c04d11d1c38f
Document Type :
article
Full Text :
https://doi.org/10.1186/1748-717X-7-174